Transparent about our performance

Every quarter, we publish our performance for key sustainability indicators related to important fish health, environmental and social topics in our operations. Below you will find the results on key sustainability figures for this quarter.

Transparency is key to corporate responsibility. Being transparent is important for the continuous improvement of Cermaq’s performance as well as for providing the basis for a good stakeholder dialogue. This is why we are publishing our sustainability results every quarter, starting from Q1 2016. In addition, you can find comprehensive information and performance data in our annual integrated report available here.

Our performance Q4 2017

CERMAQ CANADA October - December 2017

Cermaq Canada continued to deliver good overall results on social performance this quarter, with an absence rate of 2.5 percent and no lost time injuries. The environmental performance was good with no fish escapes for 2017 and no non-compliances. Sea lice levels and sea lice treatment use increased somewhat compared with the same quarter last year but were kept below regulatory limits for the quarter.  

The rolling 12 month fish survival rate improved compared with the same period last year, with a rolling survival rate of 94.3 percent; however, the use of antibiotics by closed cycle was relatively high this quarter. We describe our guidelines for antibiotic use at the end of this report below.  

CERMAQ CANADA 
INDICATOR Unit Q4 2017 Q4 2016 Calendar year 2016
FISH HEALTH
Survival rate in our fish farming (Atlantic salmon) 12 months rolling rate 94.3% 91.7% 92.0%
Use of antibiotics gAPI/t harvested 134 187 217
Use of treatments against sea lice (in feed) gAPI/t LWE produced 0.3 0.0 0.2
ENVIRONMENT
Escapes Number of fish escaped 0 0 1
Sea lice counts Average adult female and mobile lice 1.90 0.93 0.9
SOCIAL
Non-compliances Number of non-compliances closed with a fine 0 0 0
Absence rate Absentee days as a % of total work days 2.5% 1.9% 1.7%
Lost time injury rate (H1) Lost time injuries per million working hours 0 0 2
Injury frequency rate (H2) Injuries per million working hours 9 28 15
Lost time frequency rate (F-value) Lost time from injuries per million working hours 0 0

159

 

CERMAQ CHILE October - December 2017

Occupational health and safety performance continued to be good in our Chilean operations this quarter. The absence rate of 1.8 percent was unchanged compared with the same quarter last year while the lost time injury rate, injury frequency rate, and lost time frequency all decreased significantly. Two non-compliances were closed with a fine this quarter. Sea lice counts were unchanged compared with the same period last year and antibiotics use by closed cycle decreased; however, sea lice treatment use increased by 1.7 grams active ingredient per ton produced. There were no fish escapes in Cermaq Chile this quarter.

The survival rate for Atlantic Salmon and Rainbow Trout improved this quarter compared to the same period last year, with rolling survival rate of 93.8 percent for Atlantic Salmon and 96.6 percent for Trout. The survival rate for Coho Salmon decreased to 94.7 percent compared to 95.5 percent during the same period in the previous year. This quarter we had a decrease in our measure of antibiotic use compared to the same quarter last year, with a use of 304 grams active ingredient used per ton harvested compared with 554 grams per ton during Q4 2016. The main reasons for antibiotic use continues to be Piscirickettsiosis (SRS) and Bacterial Kidney Disease (BKD). We describe our guidelines for antibiotic use at the end of this report below.

Cermaq has a strong commitment to finding a sustainable solution for SRS, which currently can be partially controlled by traditional vaccination and managed by the use of antibiotics. For the last five years Cermaq’s R&D team has worked actively with industry and academic partners to develop new and effective vaccines to fight SRS, promote vaccine innovation and their proper use. Cermaq Chile will continue to work on initiatives to reduce SRS during the farming stage, by encouraging the development of new vaccine prototypes, development of novel vaccination strategies and the use of these vaccines in Cermaq Chile sites.

CERMAQ CHILE
INDICATOR Unit Q4 2017 Q4 2016 Calendar year 2016
FISH HEALTH
Survival rate in our fish farming (Atlantic salmon) 12 months rolling rate 93.8% 91.3% 92.9%
Survival rate in our fish farming (Coho) 12 months rolling rate 94.7% 95.5% 97.0%
Survival rate in our fish farming (Trout) 12 months rolling rate 96.6% 84.7% 81.6%
Use of antibiotics  gAPI/t harvested 304 554 548
Use of treatments against sea lice (bath) gAPI/t LWE produced 5.5 3.8 8.8
ENVIRONMENT
Escapes Number of fish escaped 0 0 0
Sea lice counts Average adult female lice (Caligus) 0.77 0.77 1.0
SOCIAL
Non-compliances Number of non-compliances closed with a fine 2 2 19
Absence rate Absentee days as a % of total work days 1.8% 1.8% 2.1%
Lost time injury rate (H1) Lost time injuries per million working hours 4.6 9.2 6
Injury frequency rate (H2) Injuries per million working hours 6 10 8
Lost time frequency rate (F-value) Lost time from injuries per million working hours 34 201 170

 

CERMAQ NORWAY October - December 2017

The absence rate was 4.9 percent this quarter and all injury frequency rates increased compared with the same period in 2016. There were no non-compliances this quarter and no fish escapes for the entire year of 2017.

In terms of environmental performance, sea lice counts and sea lice bath treatment were lower compared to the same period last year. The majority of farms have very good sanitary conditions. Overall lice counts are maintained well below the regulatory limit of 0.5 average adult female lice per fish.

The rolling fish survival rate improved compared with the same period last year, with a rolling survival rate of 95.7 percent this quarter. There was no use of antibiotics by closed cycle for salmon harvested this quarter in Cermaq Norway.

CERMAQ NORWAY
INDICATOR Unit Q4 2017 Q4 2016 Calendar year 2016
FISH HEALTH
Survival rate in our fish farming (Atlantic Salmon) 12 months rolling rate 95.7% 94.5% 94.8%
Use of antibiotics gAPI/t harvested 0 0.4 1.4
Use of treatments against sea lice (in bath) gAPI/t LWE produced 0.11 1.0 0.5
ENVIRONMENT
Escapes Number of fish escaped 0 400 425
Sea lice counts Average adult female lice 0.07 0.09 0.07
SOCIAL
Non-compliances Number of non-compliances closed with a fine 0 0 0
Absence rate Absentee days as a % of total work days 4.9% 4.9% 4.8%
Lost time injury rate (H1) Lost time injuries per million working hours 11 4 5.3
Injury frequency rate (H2) Injuries per million working hours 11 4 13.7
Lost time frequency rate (F-value) Lost time from injuries per million working hours 221 8 49

Our performance Q3 2017

CERMAQ CANADA July - September 2017

Cermaq Canada continued to deliver overall good results on social performance this quarter, with an absence rate of 2.1 percent, zero lost time injuries and zero injuries overall this quarter. The environmental performance was good with no fish escapes. Sea lice levels and sea lice treatment use increased somewhat compared with the same quarter last year, but counts remain well below the regulatory limit of 3 motile lice per fish. There were no non-compliances this quarter.  

The rolling 12 month fish survival rate improved compared with the same period last year and the use of antibiotics by closed cycle decreased significantly compared with the same quarter last year. This was largely due to fewer biological challenges after sea water temperatures have returned to normal levels. 

CERMAQ CANADA 
INDICATOR Unit Q3 2017 Q3 2016 Calendar year 2016
FISH HEALTH
Survival rate in our fish farming (Atlantic salmon) 12 months rolling rate 93.9% 90.6% 92.0%
Use of antibiotics gAPI/t harvested 9.2 598 217
Use of treatments against sea lice (in feed) gAPI/t LWE produced 0.3 0.01 0.2
ENVIRONMENT
Escapes Number of fish escaped 0 0 1
Sea lice counts Average adult female and mobile lice 1.0 0.6 0.9
SOCIAL
Non-compliances Number of non-compliances closed with a fine 0 0 0
Absence rate Absentee days as a % of total work days 2.1% 1.8% 1.7%
Lost time injury rate (H1) Lost time injuries per million working hours 0 0 2
Injury frequency rate (H2) Injuries per million working hours 0 8 15
Lost time frequency rate (F-value) Lost time from injuries per million working hours 0 274

159

 

CERMAQ CHILE July - September 2017

Occupational health and safety performance continued to be good in our Chilean operations this quarter. There was a lower absence rate of 1.7 percent compared with the same quarter last year while the lost time injury rate and injury frequency rate increased slightly. One non-compliance was closed with a fine this quarter. Sea lice counts were somewhat higher than in the same period last year, however sea lice treatment use decreased by nearly half. There was one unfortunate escape incident this quarter which led to the escape of an estimated 207,861 fish during a major storm. The final number of escapes will be verified after harvesting. 

The survival rate for all species improved this quarter compared to the same period last year, and the rolling mortality rate was 93.8 percent for Atlantic Salmon, 96.7 percent for Coho and 96.9 percent for Trout. This quarter we had a decrease in our measure of antibiotic use compared to the same quarter last year, with a use of 359 grams active ingredient used per tonne harvested compared with 556 grams per ton during Q3 2016. The main reasons for antibiotic use continues to be Piscirickettsiosis (SRS) and Bacterial Kidney Disease (BKD). 

Cermaq has a strong commitment to finding a sustainable solution for SRS, which currently can be partially controlled by traditional vaccination and managed by the use of antibiotics. For the last five years Cermaq’s R&D team has worked actively with industry and academic partners to develop new and effective vaccines to fight SRS, promote vaccine innovation and their proper use. Cermaq Chile will continue to work on initiatives to reduce SRS during the farming stage, by encouraging the development of new vaccines prototypes, development of novel vaccination strategies and the use of these vaccines in Cermaq Chile sites.

In Cermaq it is important that antibiotic treatments are held to a minimum, only when strictly needed to restore fish health and welfare. Our policy for the use of antibiotics is to limit the use to cases where:

  • Animal welfare is threatened by a bacterial disease
  • A diagnosis of disease exist with a prescription of antibiotic by an authorized person
  • The antibiotic has a proven therapeutic effect against the disease, and
  • The antibiotic is approved for use in fish farming
CERMAQ CHILE
INDICATOR Unit Q3 2017 Q3 2016 Calendar year 2016
FISH HEALTH
Survival rate in our fish farming (Atlantic salmon) 12 months rolling rate 93.8% 92.1% 92.9%
Survival rate in our fish farming (Coho) 12 months rolling rate 96.7% 93.3% 97.0%
Survival rate in our fish farming (Trout) 12 months rolling rate 96.9% 86.8% 81.6%
Use of antibiotics  gAPI/t harvested 359 556 548
Use of treatments against sea lice (bath) gAPI/t LWE produced 6.8 11.9 8.8
ENVIRONMENT
Escapes Number of fish escaped 207 861* 0 0
Sea lice counts Average adult female lice (Caligus) 0.97 0.60 1.0
SOCIAL
Non-compliances Number of non-compliances closed with a fine 1 1 19
Absence rate Absentee days as a % of total work days 1.7% 2.4% 2.1%
Lost time injury rate (H1) Lost time injuries per million working hours 6 4 6
Injury frequency rate (H2) Injuries per million working hours 7 6 8
Lost time frequency rate (F-value) Lost time from injuries per million working hours 123 259 170

* Escapes in Cermaq Chile this quarter are preliminary before harvesting

CERMAQ NORWAY July - September 2017

The occupational health and safety performance in Cermaq Norway this quarter remains good, with an absence rate of 3.9 percent and a significant improvement in the injury frequency rate compared with the same period in 2016. The lost time injury rate was low but increased somewhat compared with the same quarter last year. There were no non-compliances this quarter and no fish escapes.

In terms of environmental performance, sea lice counts and sea lice treatment were higher compared to the same period last year largely due to higher sea water temperatures in Nordland. Counts are still maintained well below the regulatory limit of 0.5 average adult female lice per fish.

The rolling fish survival rate improved compared with the same period last year, with a rolling survival rate of 96.1 percent this quarter. Cermaq Norway did not use any antibiotics this quarter as in the previous quarters in 2017. However, the measure of antibiotics used in this report is by closed cycle, meaning the entire production cycle of fish in the sea. Hence, there was a use of 0.8 grams of antibiotics per ton harvested on one pen(in Skinnstakkvika) of fish harvested this quarter. It was used in the fall of 2015 to treat the bacterium Tenacibaculum finnmarkense, for which there currently are no available vaccines. Cermaq's R&D team is working to find solutions to remedy this bacterium.

CERMAQ NORWAY
INDICATOR Unit Q3 2017 Q3 2016 Calendar year 2016
FISH HEALTH
Survival rate in our fish farming (Atlantic Salmon) 12 months rolling rate 96.1% 94.2% 94.8%
Use of antibiotics gAPI/t harvested 0.80 0 1.4
Use of treatments against sea lice (in bath) gAPI/t LWE produced 0.8 0.05 0.5
ENVIRONMENT
Escapes Number of fish escaped 0 15 425
Sea lice counts Average adult female lice 0.08 0.06 0.07
SOCIAL
Non-compliances Number of non-compliances closed with a fine 0 0 0
Absence rate Absentee days as a % of total work days 3.9% 3.7% 4.8%
Lost time injury rate (H1) Lost time injuries per million working hours 3 0 5.3
Injury frequency rate (H2) Injuries per million working hours 3 25 13.7
Lost time frequency rate (F-value) Lost time from injuries per million working hours 104 0 49

Our performance Q2 2017

CERMAQ CANADA April - June 2017

Cermaq Canada continued to deliver good results on social performance this quarter with no non-compliances, an absence rate of 1.0 percent and zero lost time injuries. The environmental performance was good with no fish escapes, and the overall lice situation was positive with lower sea lice counts compared to the same quarter last year. 

The rolling 12 month fish survival rate was higher compared with the same period last year, largely due to improved environmental conditions. Sea water temperatures (5 m) have returned to normal levels, which has also decreased the risk of SRS. The use of antibiotics hence decreased significantly compared with the same quarter last year.
 

CERMAQ CANADA 
INDICATOR Unit Q2 2017 Q2 2016 Calendar year 2016
FISH HEALTH
Survival rate in our fish farming (Atlantic salmon) 12 months rolling rate 94.1% 91.0% 92.0%
Use of antibiotics gAPI/t harvested 22 259 217
Use of treatments against sea lice (in feed) gAPI/t LWE produced 0.2 0.5 0.2
ENVIRONMENT
Escapes Number of fish escaped 0 1 1
Sea lice counts Average adult female and mobile lice 0.8 1.0 0.9
SOCIAL
Non-compliances Number of non-compliances closed with a fine 0 0 0
Absence rate Absentee days as a % of total work days 1.0% 1.5% 1.7%
Lost time injury rate (H1) Lost time injuries per million working hours 0 8.6 2
Injury frequency rate (H2) Injuries per million working hours 25 26 15
Lost time frequency rate (F-value) Lost time from injuries per million working hours 0 345

159

 

CERMAQ CHILE April - June 2017

Occupational health and safety performance continued to be good in our Chilean operations this quarter. There was a low injury frequency rate and lost time injury rate and a decreasing absence rate compared with the same quarter last year. Five non-compliances were closed with a fine this quarter. Sea lice counts were somewhat higher than in the same period last year, however sea lice treatment use decreased. There were two escape incidents this quarter which led to the unfortunate escape of 47 524 fish.

SRS is an industry wide threat and this burden is the main cause of fish mortalities in Chile. Antibiotic use is reported at the end of the farming cycle when the site is fully harvested. This quarter we had a significant decrease in our measure of antibiotic use compared to Q2 2016 with a use of 502 grams active ingredient used per tonne harvested by closed cycle. The main reason for antibiotic use remains Piscirickettsiosis (SRS).

Cermaq has a strong commitment to finding a sustainable solution for SRS, which currently can be partially controlled by traditional vaccination and managed by the use of antibiotics. For the last five years Cermaq’s R&D team has worked actively with industry and academic partners to develop new and effective vaccines to fight SRS, promote vaccine innovation and their proper use. Cermaq Chile will continue to work on initiatives to reduce SRS during the farming stage, by encouraging the development of new vaccines prototypes, development of novel vaccination strategies and the use of these vaccines in Cermaq Chile sites.

In Cermaq it is important that antibiotic treatments are held to a minimum, only when strictly needed to restore fish health and welfare. Our policy for the use of antibiotics is to limit the use to cases where:

  • Animal welfare is threatened by a bacterial disease
  • A diagnosis of disease exist with a prescription of antibiotic by an authorized person
  • The antibiotic has a proven therapeutic effect against the disease, and
  • The antibiotic is approved for use in fish farming
CERMAQ CHILE
INDICATOR Unit Q2 2017 Q2 2016 Calendar year 2016
FISH HEALTH
Survival rate in our fish farming (Atlantic salmon) 12 months rolling rate 93.2% 91.8% 92.9%
Survival rate in our fish farming (Coho) 12 months rolling rate 96.9% 92.8% 97.0%
Survival rate in our fish farming (Trout) 12 months rolling rate 97.0% 88.8% 81.6%
Use of antibiotics  gAPI/t harvested 502 1 527 548
Use of treatments against sea lice (bath) gAPI/t LWE produced 5.4 17.5 8.8
ENVIRONMENT
Escapes Number of fish escaped 47 524* 0 0
Sea lice counts Average adult female lice (Caligus) 1.7 1.6 1.0
SOCIAL
Non-compliances Number of non-compliances closed with a fine 5 7 19
Absence rate Absentee days as a % of total work days 1.9% 2.4% 2.1%
Lost time injury rate (H1) Lost time injuries per million working hours 6 4 6
Injury frequency rate (H2) Injuries per million working hours 7 5 8
Lost time frequency rate (F-value) Lost time from injuries per million working hours 147 146 170

* Escapes in Cermaq Chile this quarter are preliminary before harvesting

CERMAQ NORWAY April - June 2017

The occupational health and safety performance in Cermaq Norway this quarter remains good, with no lost time injuries and a somewhat lower absence rate than in the same quarter last year. There were no non-compliances this quarter and no fish escapes.

In terms of environmental performance, sea lice counts were well below the regulatory limit of 0.5 average adult female lice per fish and counts were lower than the same period last year. Lice counts were low largely due to the implementation of preventive measures such as lice skirts and several sites with cleaner fish. No sea lice treatment was used this quarter.

The rolling fish survival rate improved compared with the same period last year, with a rolling survival rate of 95.6 percent this quarter. There was no antibiotic use by closed cycle this quarter in Cermaq Norway.

CERMAQ NORWAY
INDICATOR Unit Q2 2017 Q2 2016 Calendar year 2016
FISH HEALTH
Survival rate in our fish farming (Atlantic Salmon) 12 months rolling rate 95.6% 92.2% 94.8%
Use of antibiotics gAPI/t harvested 0 4.4 1.4
Use of treatments against sea lice (in bath) gAPI/t LWE produced 0.0 1.1 0.5
ENVIRONMENT
Escapes Number of fish escaped 0 0 425
Sea lice counts Average adult female lice 0.03 0.07 0.07
SOCIAL
Non-compliances Number of non-compliances closed with a fine 0 0 0
Absence rate Absentee days as a % of total work days 4.6% 4.9% 4.8%
Lost time injury rate (H1) Lost time injuries per million working hours 0 13 5.3
Injury frequency rate (H2) Injuries per million working hours 19 18 13.7
Lost time frequency rate (F-value) Lost time from injuries per million working hours 0 146 49

Our performance Q1 2017

CERMAQ CANADA January - March 2017

In Cermaq Canada we continued to deliver good results on social performance this quarter with no non-compliances, an absence rate of 1.4 percent and zero lost time injuries. Our environmental performance was good with no fish escapes, and the overall lice situation was positive with slightly higher sea lice counts compared to same quarter last year.  Sea lice counts were kept below regulatory limits for the quarter.  

The rolling 12 month fish survival rate was lower compared with the same period last year largely due to previous environmental challenges and mouth rot in some farms. Despite these issues, the use of antibiotics decreased compared with the same quarter last year and treatment was primarily for mouth rot. After a long period of elevated sea water temperatures, the temperatures are now back to normal level, which has led to a decrease in SRS presence in several sites.

Currently there are no commercially available mouth rot vaccines in Canada. Cermaq Canada is actively engaged in both the research community and with government to better understand the mouth rot and SRS situation and to expedite vaccine development and licensing.

CERMAQ CANADA 
INDICATOR Unit Q1 2017 Q1 2016 Calendar year 2016
FISH HEALTH
Survival rate in our fish farming (Atlantic salmon) 12 months rolling rate 92.0% 93.3% 92.0%
Use of antibiotics gAPI/t harvested 12 34 217
Use of treatments against sea lice (in feed) gAPI/t LWE produced 0.2 0.2 0.2
ENVIRONMENT
Escapes Number of fish escaped 0 0 1
Sea lice counts Average adult female and mobile lice 1.11 1.08 0.87
SOCIAL
Non-compliances Number of non-compliances closed with a fine 0 0 0
Absence rate Absentee days as a % of total work days 1.4% 2.0% 1.7%
Lost time injury rate (H1) Lost time injuries per million working hours 0 0 2
Injury frequency rate (H2) Injuries per million working hours 0 0 15
Lost time frequency rate (F-value) Lost time from injuries per million working hours 0 337 159


CERMAQ CHILE January – March 2017

Occupational health and safety performance was good this quarter in our Chilean operations, with low and stable trends for absence rate, injury frequency rate and lost time injury rate compared with the same quarter last year. Nine non-compliances were closed with a fine this quarter. The environmental performance was good, with no fish escapes and sea lice counts were lower than in the same period last year.

SRS is an industry wide threat and this burden is a constant challenge and the main cause of fish mortalities in Chile. Our fish survival rates were better this quarter for Coho salmon compared with the same period last year. However, our survival rate decreased for Trout mainly due to deformities, low performance fish and predator attacks. The 12 month rolling survival rate for Atlantic salmon remained on the same levels as in Q1 2016 with 92.9 percent. The Trout survival rate decreased significantly, from 97 percent in Q1 2016 to 81.6 percent this quarter. The main reason for this was an SRS outbreak in one farming site in the 11th region which occurred several months ago. The rolling survival rate for Coho salmon improved 7 percent compared to the same period last year, mainly due to good sanitary conditions.

Antibiotic use is reported at the end of the farming cycle when the site is fully harvested. This quarter we had a decrease in our measure of antibiotic use compared to Q1 2016 with a use of 513 grams active ingredient used per tonne harvested by closed cycle. The main reason for antibiotic use remains Piscirickettsiosis (SRS). Cermaq has a strong commitment to finding a sustainable solution for SRS, which currently can be partially controlled by traditional vaccination and managed by the use of antibiotics. For the last five years Cermaq’s R&D team has worked actively with industry and academic partners to develop new and effective vaccines to fight SRS, promote vaccine innovation and proper use of them. Together with seven other industry partners including fish feed and pharmaceutical companies, Cermaq launched the Pincoy program in 2016 which aims to reduce the antibiotics use in the Chilean industry by 50 percent the next two years through a holistic approach to combat SRS. Cermaq Chile will continue to work on initiatives to reduce SRS during the farming stage, by encouraging the development of new vaccines prototypes, development of novel vaccination strategies and the use of these vaccines in Cermaq Chile sites.

In Cermaq it is important that antibiotic treatments are held to a minimum, only when strictly needed to restore fish health and welfare. Our policy for the use of antibiotics is to limit the use to cases where:

  • Animal welfare is threatened by a bacterial disease

  • A diagnosis of disease exist with a prescription of antibiotic by an authorized person

  • The antibiotic has a proven therapeutic effect against the disease, and

  • The antibiotic is approved for use in fish farming


With regard to parasitic loads, summer season is typically the most challenging time of year. Despite this, Cermaq Chile achieved lower parasitic loads with slightly higher lice treatment use for this quarter. For the past 3 years, Cermaq Chile has worked on preventive and non-pharmaceutical tools to control sea lice on their own farming sites.  The sea lice challenge is also being addressed by an industry initiative were Cermaq Chile is a member, with the aim to research and develop the use of the Chilean cleaner fish Malapterus reticulatus.

CERMAQ CHILE
INDICATOR Unit Q1 2017 Q1 2016 Calendar year 2016
FISH HEALTH
Survival rate in our fish farming (Atlantic salmon) 12 months rolling rate 92.9% 92.9%* 92.9%
Survival rate in our fish farming (Coho) 12 months rolling rate 97.0% 90%* 97.0%
Survival rate in our fish farming (Trout) 12 months rolling rate 81.6% 97%* 81.6%
Use of antibiotics  gAPI/t harvested 513 546 548
Use of treatments against sea lice (bath) gAPI/t LWE produced 7.1 6.8 8.8
ENVIRONMENT
Escapes Number of fish escaped 0 0 0
Sea lice counts Average adult female lice (Caligus) 1.01 2.47 0.98
SOCIAL
Non-compliances Number of non-compliances closed with a fine 9 0 19
Absence rate Absentee days as a % of total work days 2.0% 2.3% 2.1%
Lost time injury rate (H1) Lost time injuries per million working hours 6 7 6
Injury frequency rate (H2) Injuries per million working hours 8 9 8
Lost time frequency rate (F-value) Lost time from injuries per million working hours 108 142 170

*Algae bloom mortalities not included.


CERMAQ NORWAY January – March 2017

The occupational health and safety performance in Cermaq Norway this quarter remain good, although with higher injury and absence rates compared with the same period last year. Lost time injuries were low on 4 lost time injuries, absence was 5.8 percent and the lost time frequency rate improved significantly from 485 in Q1 2016 to 4 this quarter. There were no non-compliances this quarter and no fish escapes.

In terms of environmental performance, sea lice counts were well below the regulatory limit of 0.5 average adult female lice per fish and counts were lower than the same period last year. Lice counts were lower this quarter largely due to the implementation of preventive measures such as lice skirts and several sites with cleaner fish. Only one in feed delousing treatment was performed in Cermaq’s Norway farming sites. Development of preventive measures will be escalated further.

The rolling fish survival rate increased compared with the same period last year, with a rolling survival rate of 94.8 percent this quarter. The main reason was winter sores, parvicapsulosis and heart related disorders. There was no antibiotic use by closed cycle this quarter in Cermaq Norway.

CERMAQ NORWAY
INDICATOR Unit Q1 2017 Q1 2016 Calendar year 2016
FISH HEALTH
Survival rate in our fish farming (Atlantic Salmon) 12 months rolling rate 94.8% 92.4% 94.8%
Use of antibiotics gAPI/t harvested 0 0 1.4
Use of treatments against sea lice (in bath) gAPI/t LWE produced 0.0 1.1 0.5
ENVIRONMENT
Escapes Number of fish escaped 0 0 425
Sea lice counts Average adult female lice 0.05 0.13 0.07
SOCIAL
Non-compliances Number of non-compliances closed with a fine 0 0 0
Absence rate Absentee days as a % of total work days 5.8% 5.1% 4.8%
Lost time injury rate (H1) Lost time injuries per million working hours 4 0 5.3
Injury frequency rate (H2) Injuries per million working hours 9 0 13.7
Lost time frequency rate (F-value) Lost time from injuries per million working hours 4 485 49



Our performance Q4 2016

 CERMAQ CANADA October-December 2016

In Cermaq Canada we continued to deliver good results on social performance this quarter with no non-compliances, an absence rate of 1.9 percent and zero lost time injuries. Our environmental performance was good with no fish escapes, and the overall lice situation was positive with no sea lice treatments performed, and sea lice counts kept below regulatory limits.  

The rolling 12 month fish survival rate was lower compared with the same period last year largely due to environmental challenges, including higher water temperatures and mouth rot in some farms. Due to these challenges, during this quarter the use of antibiotics increased compared with the same quarter last year and treatment was primarily for SRS. Currently there are no commercially available SRS vaccines in Canada.  Cermaq Canada is actively engaged in both the research community and government to better understand the Canadian SRS situation and to expedite vaccine development and licensing. On a positive note, after a long period of elevated sea water temperatures, the temperatures are now back to normal level, which has led to a decrease in SRS presence in several sites.

CERMAQ CANADA

INDICATOR

Unit

Q4 2016

Q4 2015

Calendar year 2015

FISH HEALTH

Survival rate in our fish farming (Atlantic salmon)

12 months rolling rate

91.7%*

92.8%

92.8%

Use of antibiotics

gAPI/t harvested

187

56

17

Use of treatments against sea lice (in feed)

gAPI/t LWE produced

0.0

0.3

0.3

ENVIRONMENT

Escapes

Number of fish escaped

0

0

2

Sea lice counts

Average adult female and mobile lice

0.93*

1.04

1.70

SOCIAL

Non-compliances

Number of non-compliances closed with a fine

0

0

0

Absence rate

Absentee days as a % of total work days

1.9%

1.6%

2.1%

Lost time injury rate (H1)

Lost time injuries per million working hours

0

16.7

4.3

Injury frequency rate (H2)

Injuries per million working hours

28

17.0

6.4

Lost time frequency rate (F-value)

Lost time from injuries per million working hours

0

58

189

*Fish survival rate and sea lice counts were edited after auditing process in March 2017.

CERMAQ CHILE October – December 2016

Occupational health and safety performance was good this quarter in our Chilean operations, with low and stable trends for absence rate and injury frequency rate, however with a somewhat higher lost time injury rate compared with the same quarter last year. Two final non-compliances were recorded and closed during this quarter. The environmental performance was good, with no fish escapes and sea lice counts were lower than in the same period last year.

In Cermaq, we work continuously to deliver sustainable results on fish health and welfare, environmental performance and social impacts of our operations to achieve long term value creation. Regarding fish health, there are some sustainability challenges that are prevailing and that Cermaq and the industry is working to solve, including concrete challenges associated with Piscirickettsia salmonis, the agent that causes Piscirickettsiosis (SRS) in Chile.

SRS is an industry wide threat and this burden is a constant challenge and the main cause of fish mortalities in Chile. Our fish survival rates were better this quarter for Coho salmon compared with the same period last year. However, our survival rate decreased for Atlantic salmon and Trout, due to SRS outbreaks, low performance fish and predator attacks. The 12 month rolling survival rate for Atlantic salmon decreased from 94.0 percent in Q4 2015 to 91.3 percent this quarter. The Trout survival rate decreased significantly, from 97.5 percent in Q4 2015 to 84.7 percent. The main reason for this was an SRS outbreak in one farming site in the 11th region which occurred several months ago. The rolling survival rate for Coho salmon improved 4 percent compared to the same period last year, mainly due to good sanitary conditions.

This quarter we had a substantial increase in our measure of antibiotic use due to sanitary challenges because of persistent SRS outbreaks in farming sites in the 10th and 11th region.  Cermaq has a strong commitment to finding a sustainable solution for SRS, which currently can be partially controlled by traditional vaccination and managed by the use of antibiotics. For the last five years Cermaq’s R&D team has worked actively with industry and academic partners to develop new and effective vaccines to fight SRS, promote vaccine innovation and proper use of them. Last quarter, Cermaq, together with seven other industry partners including fish feed and pharmaceutical companies, launched the Pincoy program which aims to reduce the antibiotics use in the Chilean industry by 50 percent the next two years through a holistic approach to combat SRS. Cermaq Chile will continue to work on initiatives to reduce SRS during the farming stage, by encouraging the development of new vaccines prototypes, development of novel vaccination strategies and the use of these vaccines in Cermaq Chile sites.

In Cermaq it is important that antibiotic treatments are held to a minimum, only when strictly needed to restore fish health and welfare. Our policy for the use of antibiotics is to limit the use to cases where:

  • Animal welfare is threatened by a bacterial disease

  • A diagnosis of disease exist with a prescription of antibiotic by an authorized person

  • The antibiotic has a proven therapeutic effect against the disease, and

  • The antibiotic is approved for use in fish farming


For comparison, the amount of antibiotics used in Cermaq’s operations the past three years can be found in our annual reports.

With regard to parasitic loads, summer season is typically the most challenging time of year. Despite this, Cermaq Chile achieved lower parasitic loads with lower use of lice treatment this quarter. For the past 3 years, Cermaq Chile has worked on preventive and non-pharmaceutical tools to control sea lice on their own farming sites.  The sea lice challenge is also being addressed by an industry initiative were Cermaq Chile is a member, with the aim to research and develop the use of a Chilean Cleaner fish.

CERMAQ CHILE

INDICATOR

Unit

Q4 2016

Q4 2015

Calendar year 2015

FISH HEALTH

Survival rate in our fish farming (Atlantic salmon)

12 months rolling rate

91.3%

94.0%

94.0%

Survival rate in our fish farming (Coho)

12 months rolling rate

95.5%

91.5%

91.5%

Survival rate in our fish farming (Trout)

12 months rolling rate

84.7%

97.5%

97.5%

Use of antibiotics

gAPI/t harvested

554

376 

376.0

Use of treatments against sea lice (bath)

gAPI/t LWE produced

3.80

4.69

4.46

ENVIRONMENT

Escapes

Number of fish escaped

0

0

6844

Sea lice counts

Average adult female lice (Caligus)

0.77

1.37

1.41

SOCIAL

Non-compliances

Number of non-compliances closed with a fine

2

7

9

Absence rate

Absentee days as a % of total work days

1.8%

2.1%

2.2%

Lost time injury rate (H1)

Lost time injuries per million working hours

9.2

6.1

5.5

Injury frequency rate (H2)

Injuries per million working hours

10

9

9

Lost time frequency rate (F-value)

Lost time from injuries per million working hours

201

159

89

CERMAQ NORWAY October– December 2016

The occupational health and safety performance was good this quarter in Cermaq Norway. Absence decreased to 4.9 percent compared with 5.2 percent in the same period last year. There were no non-compliances this quarter and a low lost time injury rate of 4.

In terms of environmental performance, sea lice counts were well below the regulatory limit of 0.5 average adult female lice per fish and counts were lower than the same period last year. Lice counts were low this quarter largely due to the implementation of preventive measures such as lice skirts and several sites with cleanerfish. Delousing treatments were also performed in farming sites. Development of preventive measures will be escalated further.

There was one escape incident in December during a delousing treatment, leading to a loss of 400 fish. Nets to catch the escaped fish were put out immediately and 24 fish were recovered. The rolling fish survival rate was stable compared with the same period last year, with a rolling survival rate of 94.5 percent this quarter.

This quarter there was some antibiotic use by closed cycle due to some challenges with mouth rot (Tenacibaculum finnmarkense) in one farming site. The antibiotic was used in 2015 and the use is accounted at the moment of harvest which concluded in Q4 2016. Cermaq’s R&D team is working on new solutions to control this disease in partnership with a vaccine supplier.

CERMAQ NORWAY

INDICATOR

Unit

Q4 2016

Q4 2015

Calendar year 2015

FISH HEALTH

Survival rate in our fish farming (Atlantic Salmon)

12 months rolling rate

94.5%

93.8%

93.8%

Use of antibiotics

gAPI/t harvested

 0,4

4.6

Use of treatments against sea lice (in bath)

gAPI/t LWE produced

1.0

6.1

2.7

ENVIRONMENT

Escapes

Number of fish escaped

400

0

500

Sea lice counts

Average adult female lice

0.09

0.13

0.07

SOCIAL

Non-compliances

Number of non-compliances closed with a fine

0

0

2

Absence rate

Absentee days as a % of total work days

4.9%

5.2%

5.4%

Lost time injury rate (H1)

Lost time injuries per million working hours

4

12

11.0

Injury frequency rate (H2)

Injuries per million working hours

4

36.0

22.0

Lost time frequency rate (F-value)

Lost time from injuries per million working hours

8

641

521



Our performance Q4 2016

CERMAQ CANADA October-December 2016

In Cermaq Canada we continued to deliver good results on social performance this quarter with no non-compliances, an absence rate of 1.9 percent and zero lost time injuries. Our environmental performance was good with no fish escapes, and the overall lice situation was positive with no sea lice treatments performed, and sea lice counts kept below regulatory limits.  

The rolling 12 month fish survival rate was lower compared with the same period last year largely due to environmental challenges, including higher water temperatures and mouth rot in some farms. Due to these challenges, during this quarter the use of antibiotics increased compared with the same quarter last year and treatment was primarily for SRS. Currently there are no commercially available SRS vaccines in Canada.  Cermaq Canada is actively engaged in both the research community and government to better understand the Canadian SRS situation and to expedite vaccine development and licensing. On a positive note, after a long period of elevated sea water temperatures, the temperatures are now back to normal level, which has led to a decrease in SRS presence in several sites.

CERMAQ CANADA

INDICATOR

Unit

Q4 2016

Q4 2015

Calendar year 2015

FISH HEALTH

Survival rate in our fish farming (Atlantic salmon)

12 months rolling rate

91.7%*

92.8%

92.8%

Use of antibiotics

gAPI/t harvested

187

56

17

Use of treatments against sea lice (in feed)

gAPI/t LWE produced

0.0

0.3

0.3

ENVIRONMENT

Escapes

Number of fish escaped

0

0

2

Sea lice counts

Average adult female and mobile lice

0.93*

1.04

1.70

SOCIAL

Non-compliances

Number of non-compliances closed with a fine

0

0

0

Absence rate

Absentee days as a % of total work days

1.9%

1.6%

2.1%

Lost time injury rate (H1)

Lost time injuries per million working hours

0

16.7

4.3

Injury frequency rate (H2)

Injuries per million working hours

28

17.0

6.4

Lost time frequency rate (F-value)

Lost time from injuries per million working hours

0

58

189

*Fish survival rate and sea lice counts were edited after auditing process in March 2017.

CERMAQ CHILE October – December 2016

Occupational health and safety performance was good this quarter in our Chilean operations, with low and stable trends for absence rate and injury frequency rate, however with a somewhat higher lost time injury rate compared with the same quarter last year. Two final non-compliances were recorded and closed during this quarter. The environmental performance was good, with no fish escapes and sea lice counts were lower than in the same period last year.

In Cermaq, we work continuously to deliver sustainable results on fish health and welfare, environmental performance and social impacts of our operations to achieve long term value creation. Regarding fish health, there are some sustainability challenges that are prevailing and that Cermaq and the industry is working to solve, including concrete challenges associated with Piscirickettsia salmonis, the agent that causes Piscirickettsiosis (SRS) in Chile.

SRS is an industry wide threat and this burden is a constant challenge and the main cause of fish mortalities in Chile. Our fish survival rates were better this quarter for Coho salmon compared with the same period last year. However, our survival rate decreased for Atlantic salmon and Trout, due to SRS outbreaks, low performance fish and predator attacks. The 12 month rolling survival rate for Atlantic salmon decreased from 94.0 percent in Q4 2015 to 91.3 percent this quarter. The Trout survival rate decreased significantly, from 97.5 percent in Q4 2015 to 84.7 percent. The main reason for this was an SRS outbreak in one farming site in the 11th region which occurred several months ago. The rolling survival rate for Coho salmon improved 4 percent compared to the same period last year, mainly due to good sanitary conditions.

This quarter we had a substantial increase in our measure of antibiotic use due to sanitary challenges because of persistent SRS outbreaks in farming sites in the 10th and 11th region.  Cermaq has a strong commitment to finding a sustainable solution for SRS, which currently can be partially controlled by traditional vaccination and managed by the use of antibiotics. For the last five years Cermaq’s R&D team has worked actively with industry and academic partners to develop new and effective vaccines to fight SRS, promote vaccine innovation and proper use of them. Last quarter, Cermaq, together with seven other industry partners including fish feed and pharmaceutical companies, launched the Pincoy program which aims to reduce the antibiotics use in the Chilean industry by 50 percent the next two years through a holistic approach to combat SRS. Cermaq Chile will continue to work on initiatives to reduce SRS during the farming stage, by encouraging the development of new vaccines prototypes, development of novel vaccination strategies and the use of these vaccines in Cermaq Chile sites.

In Cermaq it is important that antibiotic treatments are held to a minimum, only when strictly needed to restore fish health and welfare. Our policy for the use of antibiotics is to limit the use to cases where:

  • Animal welfare is threatened by a bacterial disease

  • A diagnosis of disease exist with a prescription of antibiotic by an authorized person

  • The antibiotic has a proven therapeutic effect against the disease, and

  • The antibiotic is approved for use in fish farming


For comparison, the amount of antibiotics used in Cermaq’s operations the past three years can be found in our annual reports.

With regard to parasitic loads, summer season is typically the most challenging time of year. Despite this, Cermaq Chile achieved lower parasitic loads with lower use of lice treatment this quarter. For the past 3 years, Cermaq Chile has worked on preventive and non-pharmaceutical tools to control sea lice on their own farming sites.  The sea lice challenge is also being addressed by an industry initiative were Cermaq Chile is a member, with the aim to research and develop the use of a Chilean Cleaner fish.

CERMAQ CHILE

INDICATOR

Unit

Q4 2016

Q4 2015

Calendar year 2015

FISH HEALTH

Survival rate in our fish farming (Atlantic salmon)

12 months rolling rate

91.3%

94.0%

94.0%

Survival rate in our fish farming (Coho)

12 months rolling rate

95.5%

91.5%

91.5%

Survival rate in our fish farming (Trout)

12 months rolling rate

84.7%

97.5%

97.5%

Use of antibiotics

gAPI/t harvested

554

376 

376.0

Use of treatments against sea lice (bath)

gAPI/t LWE produced

3.80

4.69

4.46

ENVIRONMENT

Escapes

Number of fish escaped

0

0

6844

Sea lice counts

Average adult female lice (Caligus)

0.77

1.37

1.41

SOCIAL

Non-compliances

Number of non-compliances closed with a fine

2

7

9

Absence rate

Absentee days as a % of total work days

1.8%

2.1%

2.2%

Lost time injury rate (H1)

Lost time injuries per million working hours

9.2

6.1

5.5

Injury frequency rate (H2)

Injuries per million working hours

10

9

9

Lost time frequency rate (F-value)

Lost time from injuries per million working hours

201

159

89

CERMAQ NORWAY October– December 2016

The occupational health and safety performance was good this quarter in Cermaq Norway. Absence decreased to 4.9 percent compared with 5.2 percent in the same period last year. There were no non-compliances this quarter and a low lost time injury rate of 4.

In terms of environmental performance, sea lice counts were well below the regulatory limit of 0.5 average adult female lice per fish and counts were lower than the same period last year. Lice counts were low this quarter largely due to the implementation of preventive measures such as lice skirts and several sites with cleanerfish. Delousing treatments were also performed in farming sites. Development of preventive measures will be escalated further.

There was one escape incident in December during a delousing treatment, leading to a loss of 400 fish. Nets to catch the escaped fish were put out immediately and 24 fish were recovered. The rolling fish survival rate was stable compared with the same period last year, with a rolling survival rate of 94.5 percent this quarter.

This quarter there was some antibiotic use by closed cycle due to some challenges with mouth rot (Tenacibaculum finnmarkense) in one farming site. The antibiotic was used in 2015 and the use is accounted at the moment of harvest which concluded in Q4 2016. Cermaq’s R&D team is working on new solutions to control this disease in partnership with a vaccine supplier.

CERMAQ NORWAY

INDICATOR

Unit

Q4 2016

Q4 2015

Calendar year 2015

FISH HEALTH

Survival rate in our fish farming (Atlantic Salmon)

12 months rolling rate

94.5%

93.8%

93.8%

Use of antibiotics

gAPI/t harvested

 0,4

4.6

Use of treatments against sea lice (in bath)

gAPI/t LWE produced

1.0

6.1

2.7

ENVIRONMENT

Escapes

Number of fish escaped

400

0

500

Sea lice counts

Average adult female lice

0.09

0.13

0.07

SOCIAL

Non-compliances

Number of non-compliances closed with a fine

0

0

2

Absence rate

Absentee days as a % of total work days

4.9%

5.2%

5.4%

Lost time injury rate (H1)

Lost time injuries per million working hours

4

12

11.0

Injury frequency rate (H2)

Injuries per million working hours

4

36.0

22.0

Lost time frequency rate (F-value)

Lost time from injuries per million working hours

8

641

521


Our performance Q3 2016

CERMAQ CANADA July-September 2016

In Cermaq Canada we continued to deliver good results on social performance this quarter with no non-compliances, an absence rate of 1.8 percent and zero lost time injuries. Our environmental performance was good with no fish escapes, and the overall lice situation was positive with successful treatments and counts within regulated levels and less parasitic load than in same quarter last year.

The rolling 12 month fish survival rate was however lower compared with the same period last year largely due to summer related environmental concerns (e.g. gill and liver damage from plankton) and SRS in some farms. This quarter the use of antibiotics increased compared with the same quarter last year and treatment was primarily for SRS. Currently there are no commercially available SRS vaccines in Canada.  Cermaq Canada is actively engaged with both researchers and government to better understand the Canadian SRS situation and to expedite vaccine development and licensing.

CERMAQ CANADA 
INDICATOR Unit Q3 2016 Q3 2015 Calendar year 2015
FISH HEALTH
Survival rate in our fish farming (Atlantic salmon) 12 months rolling rate 90.6% 92.8% 92.8%
Use of antibiotics gAPI/tonnes harvested 598 7 17
Use of treatments against sea lice (in feed) gAPI/t LWE produced 0.0 0.3 0.3
ENVIRONMENT
Escapes Number of fish escapes 0 0 2
Sea lice counts Average adult female and mobile lice 0.58 3.11 1.70
SOCIAL
Non-compliances Number of non-compliances closed with a fine 0 0 0
Absence rate Absentee days as a % of total work days 1.8% 2.8% 2.1%
Lost time injury rate (H1) Lost time injuries per million working hours 0.0 0.0 4.3
Injury frequency rate (H2) Injuries per million working hours 7.6 0.0 6
Lost time frequency rate (F-value) Lost time from injuries per million working hours 274 191 189

CERMAQ CHILE July – September 2016

Occupational health and safety performance was good this quarter in our Chilean operations, with low and stable trends for absence rate, lost time injury rate and injury frequency rate. One minor administrative non-compliance was recorded and closed during this quarter. The environmental performance was good, with no fish escapes and sea lice counts were lower than in the same period last year.

In Cermaq, we work continuously to deliver sustainable results on fish health and welfare, environmental issues and social impacts of our operations to achieve long term value creation. Regarding fish health, there are some sustainability challenges that are prevailing and that Cermaq and the industry is working to solve, including concrete challenges associated with Piscirickettsia salmonis the agent that causes Piscirickettsiosis (SRS) in Chile.

The main cause of mortality remains SRS and challenging environmental conditions this quarter. SRS is an industry wide threat and this burden is a constant challenge and the main cause of fish mortalities and antibiotic use in Chile. The 12 month rolling survival rate for Atlantic salmon decreased from 94.2 percent in Q3 2015 to 92.1 percent this quarter. The rolling survival rate for Coho salmon decreased from 95.8 percent in Q3 2015 to 93.3 percent this quarter, and the Trout survival rate decreased from 95.3 percent in Q3 2015 to 86.8 percent. Cermaq Chile will continue to work on initiatives to reduce SRS during the farming stage, by encouraging the development of new vaccines prototypes, development of novel vaccination strategies and the use of these vaccines in Cermaq Chile sites.

Cermaq has a strong commitment to finding a sustainable solution for SRS, which currently can be partially managed by traditional vaccination and controlled by the use of antibiotics. For the last five years Cermaq’s R&D team has worked actively with industry and academic partners to develop new and effective vaccines to fight SRS, promote vaccine innovation and proper use of them. Last quarter, Cermaq, together with seven other industry partners including fish feed and pharmaceutical companies, launched the Pincoy program which aims to reduce the antibiotics use in the Chilean industry by 50 percent the next two years through a holistic approach to combat SRS.

Use of sea lice treatments increased significantly this quarter mainly due to an industry wide coordinated bath treatment performed with Chilean companies to manage the parasites before spring and summer season, when the lice is a bigger challenge. For the past 3 years, Cermaq Chile has worked on preventive and non-pharmaceutical tools to control sea lice on their own farming sites.  The sea lice challenge is also being addressed by an industry initiative were Cermaq Chile is a member, with the aim to research and develop the use of a Chilean cleaner fish.

CERMAQ CHILE
INDICATOR Unit Q3 2016 Q3 2015 Calendar year 2015
FISH HEALTH
Survival rate in our fish farming (Atlantic salmon) 12 months rolling rate 92.1% 94.2% 94.0%
Survival rate in our fish farming (Coho) 12 months rolling rate 93.3% 95.8% 91.5%
Survival rate in our fish farming (Trout) 12 months rolling rate 86.8% 95.3% 97.5%
Use of antibiotics gAPI/tonnes harvested 556 284 376.0
Use of treatments against sea lice (bath) gAPI/t LWE produced 11.9 3.0 4.46
ENVIRONMENT
Escapes Number of fish escapes 0 0 6844
Sea lice counts Average adult female lice (Caligus) 0.60 1.34 1.41
SOCIAL
Non-compliances Number of non-compliances closed with a fine 1 2 9
Absence rate Absentee days as a % of total work days 2.4% 2.2% 2.2%
Lost time injury rate (H1) Lost time injuries per million working hours 4 4 5
Injury frequency rate (H2) Injuries per million working hours 6 6 9
Lost time frequency rate (F-value) Lost time from injuries per million working hours 259 58 89

In Cermaq it is important that antibiotic treatments are held to a minimum, only when strictly needed. Our policy for the use of antibiotics is to limit the use to cases where:

  • Animal welfare is threatened by a bacterial disease

  • A diagnosis of disease exist with a prescription of antibiotic by an authorized person

  • The antibiotic has a proven therapeutic effect against the disease, and

  • The antibiotic is approved for use in fish farming


For comparison, the amount of antibiotics used in Cermaq’s operations the past three years can be found here.


CERMAQ NORWAY July– September 2016

The occupational health and safety performance was good this quarter in Cermaq Norway. Absence was 3.7 percent, which is a decrease from 4.3 percent in the same period last year. The lost time injury rate was zero, and there were no non-compliances this quarter.

In terms of environmental performance, sea lice counts were well below the regulatory limit of 0.5 average adult female lice per fish and counts were lower than the same period last year. Lice counts were low this quarter due to the implementation of preventive measures such as lice skirts and several sites with cleaner fish. Delousing treatments were also performed in farming sites. Eight bath treatments with hydrogen peroxide were conducted in Finnmark and Nordland this quarter. Development of preventive measures will be escalated further. There was one fish escape incident in August leading to 15 lost fish during a delousing treatment. The net was assessed with ROV and restored 10 minutes after the rupture detection.

The fish survival was somewhat lower than in the same period last year, with a rolling survival rate of 94.2 percent this quarter. The decrease is mainly due to common heart related disorders like HSMI and CMS in several farms in Finnmark. Cermaq Norway performed voluntary culling this quarter in sites most affected by the disease. Besides this event, the sanitary condition was good.

There has been no antibiotic use on the fish that was harvested this quarter. There are some challenges with mouth rot (Tenacibaculum finnmarkense), however no treatments were performed during this quarter. Following the identification of this bacteria, Cermaq’s R&D team is working on new solutions to control this disease.

CERMAQ NORWAY
INDICATOR Unit Q3 2016 Q3 2015 Calendar year 2015
FISH HEALTH
Survival rate in our fish farming (Atlantic Salmon) 12 months rolling rate 94.2% 95.0% 93.8%
Use of antibiotics gAPI/tonnes harvested 0.0 0.0 4.6
Use of treatments against sea lice (in bath) gAPI/t LWE produced 0.05 1.8 2.7
ENVIRONMENT
Escapes Number of fish escapes 15 500 500
Sea lice counts Average adult female lice 0.06 0.08 0.07
SOCIAL
Non-compliances Number of non-compliances closed with a fine 0 0 2
Absence rate Absentee days as a % of total work days 3.7% 4.3% 5.4%
Lost time injury rate (H1) Lost time injuries per million working hours 0.0 4 11
Injury frequency rate (H2) Injuries per million working hours 25 8 22
Lost time frequency rate (F-value) Lost time from injuries per million working hours 0.0 335 521

*The calculation of F value has been changed for Cermaq Norway from this quarter, and do no longer include lost time injuries resulting in return to limited duty /part time absence


Our performance Q2 2016

CERMAQ CANADA April – June 2016

In Cermaq Canada we continued to deliver good results on social performance this quarter with no non-compliances and an absence rate of 1.5 percent. Our environmental performance was good, though with one unfortunate incident of fish escape leading to the loss of one fish, and the overall lice situation was positive with successful treatments and counts within regulated levels and less parasitic load than in same quarter last year.

The rolling 12 month fish survival rate was lower in all year classes largely due to environmental concerns (e.g. gill and liver damage from plankton) and mouth rot in some farms. This quarter the use of antibiotics increased compared with the same quarter last year and treatment was primarily for mouth rot and SRS in some farms.

CERMAQ CANADA 
INDICATOR Unit Q2 2016 Q2 2015 Calendar year 2015
FISH HEALTH
Survival rate in our fish farming (Atlantic salmon) 12 months rolling rate 91.0% 93.6% 92.8%
Use of antibiotics gAPI/tonnes harvested 259 4 17.4
Use of treatments against sea lice (in feed) gAPI/t LWE produced 0.5 0.4 0.3
ENVIRONMENT
Escapes Number of fish escapes 1 1 2
Sea lice counts Average adult female and mobile lice 0.99 1.55 1.70
SOCIAL
Non-compliances Number of non-compliances closed with a fine 0 0 0
Absence rate Absentee days as a % of total work days 1.5% 1.9% 2.1%
Lost time injury rate (H1) Lost time injuries per million working hours 8.6 0 4.3
Injury frequency rate (H2) Injuries per million working hours 26 0.0 6.4
Lost time frequency rate (F-value) Lost time from injuries per million working hours 345 403 189

CERMAQ CHILE April – June 2016

Occupational health and safety performance was very good this quarter in our Chilean operations, with low and stable absence rate of 2.4 percent and low lost time injury rate and injury frequency rate. There were no fish escapes this quarter, however 8 non-compliances were recorded and closed.

In Cermaq, we work continuously to deliver sustainable results on fish health and welfare, environmental issues and social impacts of our operations to achieve long term value creation. Regarding fish health, there are some sustainability challenges that are prevailing and that Cermaq and the industry is working to solve, including concrete challenges associated with Piscirickettsia salmonis the agent that causes Piscirickettsiosis (SRS) in Chile.

This quarter SRS remained a challenge, but affected the survival rate less compared with the same period last year. However, we had a substantial increase in our measure of antibiotic use due to sanitary challenges due to persistent SRS outbreaks in farming sites in the 11th region.

Cermaq has a strong commitment to finding a sustainable solution for SRS, which currently can mainly be managed by not fully efficient vaccination and controlled by the use of antibiotics. For the last five years Cermaq’s R&D team has worked actively with industry and academic partners to develop new and effective vaccines to fight SRS, promote vaccine innovation and proper use of them. This quarter, Cermaq, together with seven other industry partners including feed and pharmaceutical companies, launched the Pincoy program which aims to reduce the antibiotics use in the Chilean industry by 50 percent the next two years through a holistic approach to combat SRS.

The 12 month rolling survival rate for Atlantic salmon decreased from 92.8 percent in Q2 2015 to 91.8 percent this quarter. The rolling survival rate for Coho salmon decreased this quarter compared to Q2 2015 mainly due to the effects of the harmful algae bloom. After the algae bloom events, the stocking process of Coho salmon has resumed, and the use of oral vaccination for SRS was scheduled with the aim to improve fish immunity. The Trout survival rate decreased as well, from 93.4% in Q2 2015 to 88.8% this quarter. The main cause was SRS in one farming site in the 11th region. Cermaq Chile will continue to work on initiatives to reduce SRS during the farming stage, by encouraging the development of new vaccines prototypes, development of novel vaccination strategies and the use of these vaccines in Cermaq Chile sites.

Use of sea lice treatments increased this quarter mainly due to higher sea lice counts. This Chilean autumn was in particular a very challenging season; water temperatures were higher than previous years which facilitate the sea lice growth. Also this autumn was drier than usual and ocean salinity increased, contributing to favorable conditions for lice development. For the past 3 years, Cermaq Chile has worked on preventive and non-pharmaceutical tools to control sea lice on their own farming sites.  The sea lice challenge is also being addressed by an industry initiative were Cermaq Chile is a member, with the aim to research and develop the use of a Chilean Cleaner fish.

CERMAQ CHILE
INDICATOR Unit Q2 2016 Q2 2015 Calendar year 2015
FISH HEALTH
Survival rate in our fish farming (Atlantic salmon) 12 months rolling rate 91.8% 92.8% 94.0%
Survival rate in our fish farming (Coho) 12 months rolling rate 92.8% 95.5% 91.5%
Survival rate in our fish farming (Trout) 12 months rolling rate 88.8% 93.4% 97.5%
Use of antibiotics gAPI/tonnes harvested 1527 604 376
Use of treatments against sea lice (bath) gAPI/t LWE produced 17.45 2.19 4.46
ENVIRONMENT
Escapes Number of fish escapes 0 77 6844
Sea lice counts Average adult female lice (Caligus) 1.56 1.30 1.41
SOCIAL
Non-compliances Number of non-compliances closed with a fine 7 0 9
Absence rate Absentee days as a % of total work days 2.4% 2.3% 2.2%
Lost time injury rate (H1) Lost time injuries per million working hours 4.3 6.1 5.4
Injury frequency rate (H2) Injuries per million working hours 5 8 8.6
Lost time frequency rate (F-value) Lost time from injuries per million working hours 146 69 89

CERMAQ NORWAY April – June 2016

The occupational health and safety performance was good this quarter in Cermaq Norway. Absence was 4.9 percent, which is a decrease from  5.5 percent in the same period last year. The lost time injury rate was 13 compared with 15 in Q2 2015. There were no non-compliances this quarter and no fish escapes.

In terms of environmental performance, sea lice counts were well below the regulatory limit of 0.5 average adult female lice per fish and counts were lower than the same period last year. In Nordland, counts were low this quarter due to the implementation of preventive measures such as lice skirts and several sites with lumpfish. Spring delousing treatments were performed in farming sites. Six bath treatments with hydrogen peroxide were conducted in Finnmark and one treatment was conducted in Nordland. Development of preventive measures will be escalated further.

Fish survival was somewhat inferior than in the same period last year, with a rolling survival rate of 92.2 percent this quarter. The decrease is mainly due to common heart related disorders like HSMI and CMS in several farms in Finnmark. Cermaq Norway performed voluntary culling this quarter in sites most affected by the disease. Besides this event, the sanitary condition was good.

Antibiotics use by closed cycles in Q2 2016 was low and amounted to 4.4 grams active ingredient per ton harvest. Treatments were delivered to control a disease caused by Tenacibaculum finnmarkense. Following the identification of this bacteria,  Cermaq’s R&D team is working on novel solutions to control this disease.

CERMAQ NORWAY
INDICATOR Unit Q2 2016 Q2 2015 Calendar year 2015
FISH HEALTH
Survival rate in our fish farming (Atlantic Salmon) 12 months rolling rate 92.2% 96.5% 93.8%
Use of antibiotics gAPI/tonnes harvested 4.4 0.0 4.6
Use of treatments against sea lice (in bath) gAPI/t LWE produced 1.1 1.1 2.7
ENVIRONMENT
Escapes Number of fish escapes 0 0 500
Sea lice counts Average adult female lice 0.07 0.02 0.07
SOCIAL
Non-compliances Number of non-compliances closed with a fine 0 2 2
Absence rate Absentee days as a % of total work days 4.9% 5.5% 5.4%
Lost time injury rate (H1) Lost time injuries per million working hours 13 15 11.0
Injury frequency rate (H2) Injuries per million working hours 18 20.0 21.9
Lost time frequency rate (F-value) Lost time from injuries per million working hours 146 69 521

In Cermaq it is important that antibiotic treatments are held to a minimum, only when strictly needed. Our policy for the use of antibiotics is to limit the use to cases where:

  • Animal welfare is threatened by a bacterial disease

  • A diagnosis of disease exist with a prescription of antibiotic by an authorized person

  • The antibiotic has a proven therapeutic effect against the disease, and

  • The antibiotic is approved for use in fish farming


For comparison, the amount of antibiotics used in Cermaq’s operations the past three years can be found in 2015 report.


Our performance Q1 2016

CERMAQ CANADA

In Cermaq Canada we continued to deliver good results on social indicators this quarter, with zero injuries among our employees and zero non-compliances in our operations. Our absence rate was stable and low. Our environmental performance was good, with no fish escapes and the overall lice situation was positive with successful treatments and counts within regulated levels (which is 3 average adult female and mobile lice per fish). Fish survival (rolling 12 months rate) was high in all year classes with no significant disease concern this quarter.

In Cermaq, it is very important that antibiotic treatments are held to a minimum, only when strictly needed. Our policy for the use of antibiotics is to limit the use to cases where:

  • Animal welfare is threatened by a bacterial disease
  • A diagnosis of disease exist with a prescription of antibiotic by an authorized person
  • The antibiotic has a proven therapeutic effect against the disease, and
  • The antibiotic is approved for use in fish farming

For comparison, the amount of antibiotics used in Cermaq’s operations the past three years can be found in our annual sustainability report, available  here.

CERMAQ CANADA 
INDICATOR Unit Q1 2016 Q1 2015 Calendar year 2015
FISH HEALTH
Survival rate in our fish farming (Atlantic salmon) 12 months rolling rate 93.3% 93.8% 92.8%
Use of antibiotics gAPI/tonnes harvested 33.6 11.8 17.4
Use of treatments against sea lice (in feed) gAPI/t LWE produced 0.2 0.1 0.3
ENVIRONMENT
Escapes Number of fish escapes 0 1 2
Sea lice counts Average adult female and mobile lice 1.28 1.10 1.70
SOCIAL
Non-compliances Number of non-compliances closed with a fine 0 0 0
Absence rate Absentee days as a % of total work days 2.0% 2.3% 2.1%
Lost time injury rate (H1) Lost time injuries per million working hours 0 0 4.3
Injury frequency rate (H2) Injuries per million working hours 0 9.0 6.4
Lost time frequency rate (F-value) Lost time from injuries per million working hours 337 99 189

CERMAQ CHILE

In our Chilean operations, there were no final non-compliances this quarter and no fish escapes. Occupational health and safety performance was good, with a low and stable absence rate of 2.3 percent and low lost time injury rate and injury frequency rate.

In Cermaq, we work continuously to deliver sustainable results on fish health and welfare, environmental issues and social impacts of our operations to achieve long term value creation. Regarding fish health, there are some sustainability challenges that are prevailing and that Cermaq and the industry is working to solve, including concrete challenges associated with well-known parasites and disease agents such as Salmonid Rickettsial Septicaemia (SRS) in Chile.

The Chilean salmon industry, including Cermaq, was strongly affected by harmful algae blooms this quarter, leading to an average loss of 12 percent of the annual total production of the industry (SalmonChile). During this environmental challenge, Cermaq Chile made a strong effort to properly handle all fish diseased caused by the algae blooms and ensure proper disposal to minimize any negative effects on the environment. No diseased fish was disposed at sea.

Fish health impacts from the algae blooms include damage on the gills from the algae lowering the oxygen intake and increased stress levels making the fish more exposed to disease. A consequence may also be higher sea lice counts because treatments need to be suspended on many sites due to the algae presence. Sea lice treatments may also be suspended to avoid more stress on the Fish.

Not considering the algae blooms, we had an improvement in the rolling survival rate of Atlantic salmon in our Chilean operations compared with the same quarter last year; from 90.3 percent in Q1 2015 to to 92.9 percent this quarter. The rolling survival rate of Coho salmon was slightly reduced, while Trout survival rate improved by 6.4 percent compared with the same quarter last year. Sea lice bath treatment in Cermaq Chile increased somewhat this quarter because of the above mentioned challenges, but also partly because treatment use is a measure of the ratio of active ingredient used per live biomass in the water, and increased algae bloom mortalities lead to a decrease of live fish in the pens. Bath treatment use was lower this quarter than the same period last year.

Cermaq has a strong commitment to finding a sustainable solution for SRS, which currently can mainly be controlled by antibiotics. For the last five years Cermaq’s R&D team has worked actively with industry and academic partners to develop new and effective vaccines to fight SRS and ensure their proper use.

This quarter, we had an increase in our measure of antibiotic use. Cermaq measures the antibiotic use as a ratio of active ingredient used per harvested tonnes by closed cycles. Beside some impacts on this indicator by the algae blooms, there is no doubt that antibiotic use has increased in Cermaq Chile this past quarter. This Summer season was recorded as an unusual dry Summer with higher temperatures than previous years (due to the “El niño” phenomenon), providing ideal conditions for bacterial disease development, in this case SRS. The outbreaks were more recurrent on Atlantic salmon and even in Coho salmon where Cermaq typically has had a strong long term performance due to our well established genetics program. Worsened environmental conditions are hence the main explanation of the increase in antibiotic use.

CERMAQ CHILE
INDICATOR Unit Q1 2016 Q1 2015 Calendar year 2015
FISH HEALTH
Survival rate in our fish farming (Atlantic salmon) 12 months rolling rate 92.9%* 90.3% 94.0%
Survival rate in our fish farming (Coho) 12 months rolling rate 90%* 93.9% 91.5%
Survival rate in our fish farming (Trout) 12 months rolling rate 97.0%* 90.6% 97.5%
Use of antibiotics gAPI/tonnes harvested 546.0 252.0 376.0
Use of treatments against sea lice (bath) gAPI/t LWE produced 6.20 9.01 4.46
ENVIRONMENT
Escapes Number of fish escapes 0 0 6844
Sea lice counts Average adult female lice (Caligus) 2.47 1.65 1.41
SOCIAL
Non-compliances Number of non-compliances closed with a fine 0 0 9
Absence rate Absentee days as a % of total work days 2.3% 2.3% 2.2%
Lost time injury rate (H1) Lost time injuries per million working hours 6.5 6 5.4
Injury frequency rate (H2) Injuries per million working hours 8.9 11 8.6
Lost time frequency rate (F-value) Lost time from injuries per million working hours 142 62 89

* Algae bloom mortalities not included.

CERMAQ NORWAY

The occupational health and safety performance was very good this quarter in Cermaq Norway, with zero lost time injuries and a injury frequency rate of zero. Absence was stable around 5 percent this quarter, a level which is related to seasonal challenges such as flu. There were no non-compliances this quarter.

In terms of environmental performance, there were no fish escape incidents in Cermaq Norway this quarter and sea lice counts were well below the regulatory limit of 0.5 average adult female lice per fish. Sea lice counts were however higher than in the same period last year. This was mainly due to the increased lice levels in Finnmark last autumn, where levels have kept higher than usual. Due to low sea temperatures and rough weather conditions there have been a few cases where treatment could not be performed. Most farms in Finnmark will be deloused in the obligatory spring delousing. In Nordland, counts were low this quarter due to the implementation of preventive measures such as lice skirts and several sites with lumpfish. One treatment with hydrogen peroxide was conducted in Nordland this quarter. Development of preventive, non-chemical measures will be escalated in 2016.

The rolling fish survival rate was somewhat lower compared with the same quarter last year, with a survival rate of 92.4 percent this quarter. The decrease is mainly due to common heart related disorders like HSMI and CMS in some farms, but a significant portion in Finnmark can be explained by sores and Parvicapsulosis in some farms. Overall, the sanitary conditions is good this quarter with no use of antibiotics.

CERMAQ NORWAY
INDICATOR Unit Q1 2016 Q1 2015 Calendar year 2015
FISH HEALTH
Survival rate in our fish farming (Atlantic Salmon) 12 months rolling rate 92.4% 95.4% 93.8%
Use of antibiotics gAPI/tonnes harvested 0.0 18.0 4.6
Use of treatments against sea lice (in bath) gAPI/t LWE produced 1.1 0.0 2.7
ENVIRONMENT
Escapes Number of fish escapes 0 0 500
Sea lice counts Average adult female lice 0.13 0.05 0.07
SOCIAL
Non-compliances Number of non-compliances closed with a fine 0 0 2
Absence rate Absentee days as a % of total work days 5.1% 6.5% 5.4%
Lost time injury rate (H1) Lost time injuries per million working hours 0 19.0 11.0
Injury frequency rate (H2) Injuries per million working hours 0 23.0 21.9
Lost time frequency rate (F-value) Lost time from injuries per million working hours 485 595 521

How each indicator is measured

Fish health

Fish survival: The welfare status of farmed fish is of interest to a range of industry stakeholders. In Cermaq, we continuously strive to improve fish welfare through a range of measures and initiatives.

Survival can be used as one simple measure to gain an overview of the fish health situation. The indicator is a rolling 12 month measure which calculates survival number for the last 12 months as a proportion of the estimated number of fish in the sea in the last 12 month of the year (adjusted for harvest and mortalities). This is to adjust for short term variations and to enable to show longer term trends.

Antibiotic use: Medicines is a necessary tool in all kinds of animal farming to ensure animal welfare. In salmon farming, some geographical regions or companies have been able to significantly reduce their use of antibiotics over time, whilst others are relatively high users. This measure is useful to gain an overview and control of the antibiotics use in the operations, and ensure that our antibiotic policy is adhered to. We measure the total use of antibiotics divided on the biomass harvested within a quarter. We have chosen this measure as we consider that it gives the best indication of the sustainability of our production and product safety. Also this measure gives a good relation between antibiotic use and stock treated by period and provides better association between treatments and final products.

In Cermaq it is important that antibiotic treatments are held to a minimum, only when strictly needed to restore fish health and welfare. Our policy for the use of antibiotics is to limit the use to cases where:

  • Animal welfare is threatened by a bacterial disease
  • A diagnosis of disease exist with a prescription of antibiotic by an authorized person
  • The antibiotic has a proven therapeutic effect against the disease, and
  • The antibiotic is approved for use in fish farming

Sea lice treatment: This indicator seeks to quantify the amount of different types of sea lice treatment used by Cermaq. Bath treatments and in-feed treatments are included in the indicator, where the most significant by region is published. Preventive methods are not included in the reporting; only treatments to ensure that sea lice levels are in compliance with regulatory set limits. A summary of non-pharmaceutical and preventive measures used in Cermaq, can be seen here. In Canada, only treatment in feed is used, while in Norway and Chile, bath treatments are most common are hence reported here. Treatments with hydrogen peroxide is not included in this figure.

Escapes: Our goal in Cermaq is zero escapes. Escapes may pose negative effects through possible interaction between the escaped salmon and wild salmon including the risk of compromising genetic integrity and increase competition in the freshwater environment. For fish farmers, escapes also represent a loss of valuable assets. Preventing escapes is a high priority and in the case of any incidents of escape, we work intensively to recapture as many fish as possible. This indicator aims to quantify the number and extent of fish escape incidents and what action has been taken to prevent recurrence, to minimize the risk of similar incidents in the future.

Environment

Sea lice counts: Sea lice represent a continuing challenge across operations in many regions. Control of sea lice in a sustainable way is critical to the future sustainability and growth of the salmon farming industry. We are therefore closely monitoring the sea lice counts in each region to gain an overview of the lice situation in Cermaq. Counts are made for each site, and the number reported here represents an average of each Cermaq operating company. The lice counting for each country is linked to the sea lice levels triggering treatment in the different salmon farming areas.

Non-compliances: Our clear goal is to comply with all applicable laws and regulations in our countries of operation. The level of any non-compliances within our operating companies also helps indicate our ability to ensure that operations conform to expected performance parameters. From an economic perspective, ensuring compliance helps to reduce financial risks that occur either directly through fines or indirectly through impacts on reputation. This indicator seeks to measure the compliance with environmental, social, and product regulations in our operations. It refers to final non-compliances closed with a fine.

OHS

Cermaq employees shall be safe and secure at work. Occupational health and safety initiatives are integral parts of the Group’s risk management. The OHS challenges are differing between the operating companies. Each operating company identifies its own relevant and suited initiatives to reduce the level of injuries and absence due to illness. Operating companies also engage regularly in the sharing of best practices to manage and mitigate common challenges, including the definition and measurement of a set of common OHS indicators reported monthly to the management.

Absence rate: This indicator measures absence related to employees’ health including sickness, lost time from injuries (at work or outside work), or occupational disease.

Lost time injury rate (H1): This indicator measures injuries among our employees that lead to lost time direct per million working hours.

Injury frequency rate (H2): This indicator measures the total number of injuries among our employees per million working hours.

Lost time frequency rate (F-value): This indicators measures lost time from injuries among our employees per million working hours.

 

Links:

Sustainability indicators in the annual report

Cermaq's policy on antibiotics

GSI Dashboard (Global Salmon Initiative) 

 


Annual sustainability report

Cermaq's annual sustainability report follows the calendar year and is audited by third party.

The annual sustainability report for 2016.


Back to top